TGFB1 and myocardial infarction: Inhibition of Safe could prevent TGF‐β-induced activation of fibroblast proliferation, fibroblast-myofibroblast transition, and collagen secretion, thus restraining cardiac fibrosis and improving cardiac function after myocardial infarction.